SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Intel Strategy for Achieving Wealth and Off Topic -- Ignore unavailable to you. Want to Upgrade?


To: Sonki who wrote (12782)11/4/1997 5:07:00 PM
From: Sonki  Respond to of 27012
 
hum ! i used to have this stock... (VICL) 14 13/16 +5/16: company signs an agreement granting Merck (MRK) rights to develop and market therapeutic vaccines against the
human immunodeficiency virus (HIV) and the hepatitis B virus (HBV) using Vical's patented "naked" DNA technology. In return, MRK will make an equity
investment at a price above fair market value. Vical may also receive up to $18 million in milestone payments...